Figure 2. mRNA biodistribution does not indicate sites of mRNA translation.
(A) To assess biodistribution, mice received IV injections of LNPs carrying Cy5-labeled mRNA at a dose of 0.75 mg/kg. LNPs predominantly distributed to the liver and to the spleen, lungs, and kidneys to a lesser extent. (B) Protein expression was determined by injecting mice via tail vein with LNPs carrying unmodified luciferase mRNA at a dose of 0.75 mg/kg. C12-200 and cKK-E12 facilitated protein expression almost entirely in the liver. 200Oi10 delivery resulted in a more diverse expression profile, as did ZA3-Ep10, with 70% of luciferase expression occurring in the lungs.